Docking screens: Right for the right reasons?

Current Topics in Medicinal Chemistry

Volumn 9, Issue 9, 2009, Pages 755-770

  Kolb, Peter ^a   Irwin, John J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ligand discovery; Virtual screening

Indexed keywords

LIGAND; PROTEIN;

CRYSTAL STRUCTURE; HUMAN; MOLECULAR DOCKING; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN STRUCTURE; REVIEW; CHEMICAL STRUCTURE; COMPUTER SIMULATION; DRUG ANTAGONISM; DRUG SCREENING; METHODOLOGY;

COMPUTER SIMULATION; DRUG EVALUATION, PRECLINICAL; LIGANDS; MOLECULAR STRUCTURE; PROTEIN BINDING; PROTEINS;

EID: 73449145345     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802609789207091     Document Type: Review

References (74)

1. Leach, A. R.; Shoichet, B. K.; Peishoff, C. E. Prediction of protein-ligand interactions. Docking and scoring: successes and gaps. J. Med. Chem. 2006, 49, 5851-5855.
2. Shoichet, B. K. Virtual screening of chemical libraries. Nature 2004, 432, 862-865.
3. Friesner, R. A.; Banks, J. L.; Murphy, R. B.; Halgren, T. A.; Klicic, J. J.; Mainz, D. T.; Repasky, M. P.; Knoll, E. H.; Shelley, M.; Perry, J. K.; Shaw, D. E.; Francis, P.; Shenkin, P. S. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 2004, 47, 1739-1749.
4. Perola, E.; Walters, W. P.; Charifson, P. S. A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance. Proteins 2004, 56, 235-49.
5. Brooijmans, N.; Kuntz, I. D. Molecular recognition and docking algorithms. Annu. Rev. Biophys. Biomol. Struct. 2003, 32, 335-73.
6. Kellenberger, E.; Rodrigo, J.; Muller, P.; Rognan, D. Comparative evaluation of eight docking tools for docking and virtual screening accuracy. Proteins 2004, 57, 225-42.
7. Gohlke, H.; Klebe, G. Statistical potentials and scoring functions applied to protein-ligand binding. Curr. Opin. Struct. Biol. 2001, 11, 231-5.
8. Halperin, I.; Ma, B.; Wolfson, H.; Nussinov, R. Principles of Docking: An Overriew of Search Algorithms and a Guide to Scoring Functions. Proteins 2002, 47, 409-443.
9. Stahl, M.; Rarey, M. Detailed analysis of scoring functions for virtual screening. J. Med. Chem. 2001, 44, 1035-1042.
10. Ferrara, P.; Gohlke, H.; Price, D. J.; Klebe, G.; Brooks, C. L., III. Assessing scoring functions for protein-ligand interactions. J. Med. Chem. 2004, 47, 3032-47.
11. Wang, R.; Lu, Y.; Fang, X.; Wang, S. An extensive test of 14 scoring functions using the PDBbind refined set of 800 protein-ligand complexes. J. Chem. Inf. Comput. Sci. 2004, 44, 2114-25.
12. Velec, H. F.; Gohlke, H.; Klebe, G. DrugScore(CSD)-knowledge-based scoring function derived from small molecule crystal data with superior recognition rate of near-native ligand poses and better affinity prediction. J. Med. Chem. 2005, 48, 6296-303.
13. Moustakas, D. T.; Lang, P. T.; Pegg, S.; Pettersen, E.; Kuntz, I. D.; Brooijmans, N.; Rizzo, R. C. Development and validation of a modular, extensible docking program: DOCK 5. J. Comput.-Aided Mol. Des. 2006, 20, 601-19.
14. Warren, G. L.; Andrews, C. W.; Capelli, A. M.; Clarke, B.; LaLonde, J.; Lambert, M. H.; Lindvall, M.; Nevins, N.; Semus, S. F.; Senger, S.; Tedesco, G.; Wall, I. D.; Woolven, J. M.; Peishoff, C. E.; Head, M. S. A critical assessment of docking programs and scoring functions. J. Med. Chem. 2006, 49, 5912-31.
15. Hartshorn, M. J.; Verdonk, M. L.; Chessari, G.; Brewerton, S. C.; Mooij, W. T.; Mortenson, P. N.; Murray, C. W. Diverse, high-quality test set for the validation of protein-ligand docking performance. J. Med. Chem. 2007, 50, 726-41.
16. Verdonk, M. L.; Cole, J. C.; Hartshorn, M. J.; Murray, C. W.; Taylor, R. D. Improved protein-ligand docking using GOLD. Proteins 2003, 52, 609-23.
17. Gradler, U.; Gerber, H. D.; Goodenough-Lashua, D. M.; Garcia, G. A.; Ficner, R.; Reuter, K.; Stubbs, M. T.; Klebe, G. A new target for shigellosis: rational design and crystallographic studies of inhibitors of tRNA-guanine transglycosylase. J. Mol. Biol. 2001, 306, 455-67.
18. Horn, J. R.; Shoichet, B. K. Allosteric inhibition through core disruption. J. Mol. Biol. 2004, 336, 1283-91.
19. Powers, R. A.; Morandi, F.; Shoichet, B. K. Structure-based discovery of a novel, noncovalent inhibitor of AmpC β-lactamase. Structure 2002, 10, 1013-1023.
20. Tondi, D.; Morandi, F.; Bonnet, R.; Costi, M. P.; Shoichet, B. K. Structure-based optimization of a non-beta-lactam lead results in inhibitors that do not up-regulate β-lactamase expression in cell culture. J. Am. Chem. Soc. 2005, 127, 4632-9.
21. Burkhard, P.; Taylor, P.; Walkinshaw, M. D. An example of a protein ligand found by database mining: description of the docking method and its verification by a 2.3 A X-ray structure of a thrombin-ligand complex. J. Mol. Biol. 1998, 277, 449-66.
22. Shoichet, B. K.; Stroud, R. M.; Santi, D. V.; Kuntz, I. D.; Perry, K. M. Structure-based discovery of inhibitors of thymidylate synthase. Science 1993, 259, 1445-1450.
23. Pereira, H. M.; Berdini, V.; Cleasby, A.; Garratt, R. C. Crystal structure of calf spleen purine nucleoside phosphorylase complexed to a novel purine analogue. FEBS Lett. 2007, 581, 5082-6.
24. Graves, A. P.; Shivakumar, D. M.; Boyce, S. E.; Jacobson, M. P.; Case, D. A.; Shoichet, B. K. Rescoring docking hit lists for model cavity sites: predictions and experimental testing. J. Mol. Biol. 2008, 377, 914-34.
25. Wei, B. Q.; Baase, W. A.; Weaver, L. H.; Matthews, B. W.; Shoichet, B. K. A model binding site for testing scoring functions in molecular docking. J. Mol. Biol. 2002, 322, 339-355.
26. Graves, A. P.; Brenk, R.; Shoichet, B. K. Decoys for docking. J. Med. Chem. 2005, 48, 3714-28.
27. Brenk, R.; Vetter, S. W.; Boyce, S. E.; Goodin, D. B.; Shoichet, B. K. Probing molecular docking in a charged model binding site. J. Mol. Biol. 2006, 357, 1449-70.
28. Chen, Y.; Shoichet, B. K. Molecular docking and ligand specificity in fragment-based inhibitor discovery. Nat. Chem. Biol. 2009, 5(5), 358-64.
29. Teotico, D.G.; Babaoglu, K.; Rocklin, G.J.; Ferreira, R.S.; Giannetti, A.M.; Shoichet, B.K. Proc. Natl. Acad. Sci. USA 2009, 106(18), 7455-60.
30. Hermann, J. C.; Marti-Arbona, R.; Fedorov, A. A.; Fedorov, E.; Almo, S. C.; Shoichet, B. K.; Raushel, F. M. Structure-based activity prediction for an enzyme of unknown function. Nature 2007, 448, 775-U2.
31. Babaoglu, K.; Simeonov, A.; Lrwin, J. J.; Nelson, M. E.; Feng, B.; Thomas, C. J.; Cancian, L.; Costi, M. P.; Maltby, D. A.; Jadhav, A.; Inglese, J.; Austin, C. P.; Shoichet, B. K. Comprehensive mechanistic analysis of hits from high-throughput and docking screens against β-lactamase. J. Med. Chem. 2008, 51, 2502-2511.
32. Wu, S. Y.; McNae, I.; Kontopidis, G.; McClue, S. J.; McInnes, C.; Stewart, K. J.; Wang, S.; Zheleva, D. I.; Marriage, H.; Lane, D. P.; Taylor, P.; Fischer, P. M.; Walkinshaw, M. D. Discovery of a novel family of CDK inhibitors with the program LIDAEUS: structural basis for ligand-induced disordering of the activation loop. Structure 2003, 11, 399-410.
33. Kurinov, I. V.; Harrison, R. W. Prediction of new serine proteinase inhibitors. Nat. Struct. Biol. 1994, 1, 735-43.
34. Tondi, D.; Slomczynska, U.; Costi, M. P.; Watterson, D. M.; Ghelli, S.; Shoichet, B. K. Structure-based discovery and inparallel optimization of novel competitive inhibitors of thymidylate synthase. Chem. Biol. 1999, 6, 319-31.
35. Lu, I. L.; Mahindroo, N.; Liang, P. H.; Peng, Y. H.; Kuo, C. J.; Tsai, K. C.; Hsieh, H. P.; Chao, Y. S.; Wu, S. Y. Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease. J. Med. Chem. 2006, 49, 5154-61.
36. Schuttelkopf, A. W.; Andersen, O. A.; Rao, F. V.; Allwood, M.; Lloyd, C.; Eggleston, I. M.; van Aalten, D. M. Screening-based discovery and structural dissection of a novel family 18 chitinase inhibitor. J. Biol. Chem. 2006, 281, 27278-85.
37. Foloppe, N.; Fisher, L. M.; Howes, R.; Potter, A.; Robertson, A. G. S.; Surgenor, A. E. Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening. Bioorg. Med. Chem. 2006, 14, 4792-4802.
38. Gruneberg, S.; Stubbs, M. T.; Klebe, G. Successful virtual screening for novel inhibitors of human carbonic anhydrase: strategy and experimental confirmation. J. Med. Chem. 2002, 45, 3588-602.
39. Krämer, O.; Hazemann, I.; Podjarny, A. D.; Klebe, G. Virtual screening for inhibitors of human aldose reductase. Proteins 2004, 55, 814-823.
40. Steuber, H.; Heine, A.; Klebe, G. Structural and thermodynamic study on aldose reductase: nitro-substituted inhibitors with strong enthalpic binding contribution. J. Mol. Biol. 2007, 368, 618-38.
41. Xu, L.; Li, C. L.; Olson, A. J.; Wilson, I. A. Crystal structure of avian aminoimidazole-4-carboxamide ribonucleotide transformylase in complex with a novel non-folate inhibitor identified by virtual ligand screening. J. Biol. Chem. 2004, 279, 50555-50565.
42. Li, C. L.; Xu, L.; Wolan, D. W.; Wilson, I. A.; Olson, A. J. Virtual screening of human 5-aminoimidazole-4-carboxamide ribonucleotide transformylase against the NCI diversity set by use of AutoDock to identify novel nonfolate inhibitors. J. Med. Chem. 2004, 47, 6681-6690.
43. Barril, X.; Brough, P.; Drysdale, M.; Hubbard, R. E.; Massey, A.; Surgenor, A.; Wright, L. Structure-based discovery of a new class of Hsp90 inhibitors. Bioorg. Med. Chem. Lett. 2005, 15, 5187-91.
44. Huang, N.; Shoichet, B. K.; Irwin, J. J. Benchmarking sets for molecular docking. J. Med. Chem. 2006, 49, 6789-6801.
45. Hert, J.; Keiser, M. J.; Irwin, J. J.; Oprea, T. I.; Shoichet, B. K. Quantifying the relationships among drug classes. J. Chem. Inf. Model. 2008, 48, 755-65.
46. Hann, M. M.; Leach, A. R.; Harper, G. Molecular complexity and its impact on the probability of finding leads for drug discovery. J. Chem. Inf. Comput. Sci. 2001, 41, 856-64.
47. Jhoti, H. Fragment-based drug discovery using rational design. Ernst Schering Found. Symp. Proc. 2007, 3, 169-85.
48. Mizutani, M. Y.; Itai, A. Efficient method for high-throughput virtual screening based on flexible docking: Discovery of novel acetylcholinesterase inhibitors. J. Med. Chem. 2004, 47, 4818-4828.
49. Brooks, W. H.; McCloskey, D. E.; Daniel, K. G.; Ealick, S. E.; Secrist, J. A.; Waud, W. R.; Pegg, A. E.; Guida, W. C. In silico chemical library screening and experimental validation of a novel 9-aminoacridine based lead-inhibitor of human S-adenosylmethionine decarboxylase. J. Chem. Inf. Model. 2007, 47, 1897-1905.
50. Wang, J. G.; Xiao, Y. J.; Li, Y. H.; Ma, Y.; Li, Z. M. Identification of some novel AHAS inhibitors via molecular docking and virtual screening approach. Bioorg. Med. Chem. 2007, 15, 374-380.
51. Rosenfeld, R. J.; Goodsell, D. S.; Musah, R. A.; Morris, G. M.; Goodin, D. B.; Olson, A. J. Automated docking of ligands to an artificial active site: augmenting crystallographic analysis with computer modeling. J. Comput.-Aided Mol. Des. 2003, 17, 525-36.
52. Montes, M.; Braud, E.; Miteva, M. A.; Goddard, M. L.; Mondesert, O.; Kolb, S.; Brun, M. P.; Ducommun, B.; Garbay, C.; Villoutreix, B. O. Receptor-based virtual ligand screening for the identification of novel CDC25 phosphatase inhibitors. J. Chem. Inf. Model. 2008, 48, 157-165.
53. Cregge, R. J.; Durham, S. L.; Farr, R. A.; Gallion, S. L.; Hare, C. M.; Hoffman, R. V.; Janusz, M. J.; Kim, H. O.; Koehl, J. R.; Mehdi, S.; Metz, W. A.; Peet, N. P.; Pelton, J. T.; Schreuder, H. A.; Sunder, S.; Tardif, C. Inhibition of human neutrophil elastase. 4. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of P2-modified, orally active peptidyl pentafluoroethyl ketones. J. Med. Chem. 1998, 41, 2461-80.
54. Vulpetti, A.; Casale, E.; Roletto, F.; Amici, R.; Villa, M.; Pevarello, P. Structure-based drug design to the discovery of new 2-aminothiazole CDK2 inhibitors. J. Mol. Graph. 2006, 24, 341-8.
55. Li, J.; Zhang, J.; Chen, J.; Luo, X. M.; Zhu, W. L.; Shen, J. H.; Liu, H.; Shen, X.; Jiang, H. L. Strategy for discovering chemical inhibitors of human cyclophilin A: Focused library design, virtual screening, chemical synthesis and bioassay. J. Comb. Chem. 2006, 8, 326-337.
56. Ostrov, D. A.; Prada, J. A. H.; Corsino, P. E.; Finton, K. A.; Le, N.; Rowe, T. C. Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening. Antimicrob. Agents Chemother. 2007, 51, 3688-3698.
57. Kolb, P.; Berset Kipouros, C.; Huang, D.; Caflisch, A. Structure-based tailoring of compound libraries for high-throughput screening: Discovery of novel EphB4 inhibitors. Proteins 2008. 73(1), 11-8.
58. Tikhonova, I. G.; Sum, C. S.; Neumann, S.; Engel, S.; Raaka, B. M.; Costanzi, S.; Gershengorn, M. C. Discovery of novel Agonists and antagonists of the free fatty acid receptor 1 (FFAR1) using virtual screening. J. Med. Chem. 2008, 51, 625-633.
59. Kiss, R.; Kiss, B.; Konczol, A.; Szalai, F.; Jelinek, I.; Laszlo, V.; Noszal, B.; Falus, A.; Keseru, G. M. Discovery of Novel Human Histamine H4 Receptor Ligands by Large-Scale Structure-Based Virtual Screening. J. Med. Chem. 2008.
60. Lemaire, G.; Benod, C.; Nahoum, V.; Pillon, A.; Boussioux, A. M.; Guichou, J. F. O.; Subra, G.; Pascussi, J. M.; Bourguet, W.; Chavanieu, A.; Balaguer, P. Discovery of a highly active ligand of human pregnane X receptor: a case study from pharmacophore Modeling and virtual screening to "in vivo" biological activity. Mol. Pharmacol. 2007, 72, 572-581.
61. Zhou, Y.; Peng, H.; Ji, Q.; Qi, J.; Zhu, Z. P.; Yang, C. Z. Discovery of small molecule inhibitors of integrin alpha v beta 3 through structure-based virtual screening. Bioorg. Med. Chem. Lett. 2006, 16, 5878-5882.
62. Cavasotto, C. N.; Orry, A. J. W.; Murgolo, N. J.; Czarniecki, M. F.; Kocsi, S. A.; Hawes, B. E.; O'Neill, K. A.; Hine, H.; Burton, M. S.; Voigt, J. H.; Abagyan, R. A.; Bayne, M. L.; Monsma, F. J. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening. J. Med. Chem. 2008, 51, 581-588.
63. Pierce, A. C.; Jacobs, M.; Stuver-Moody, C. Docking study yields four novel inhibitors of the protooncogene Pim-1 kinase. J. Med. Chem. 2008, 51, 1972-1975.
64. Salam, N. K.; Huang, T. H. W.; Kota, B. P.; Kim, M. S.; Li, Y. H.; Hibbs, D. E. Novel PPAR-gamma agonists identified from a natural product library: A virtual screening, induced-fit docking and biological assay study. Chem. Biol. Drug Des. 2008, 71, 57-70.
65. Engel, S.; Skoumbourdis, A. P.; Childress, J.; Neumann, S.; Deschamps, J. R.; Thomas, C. J.; Colson, A. O.; Costanzi, S.; Gershengorn, M. C. A virtual screen for diverse ligands: Discovery of selective G protein-coupled receptor antagonists. J. Am. Chem. Soc. 2008, 130, 5115-5123.
66. 2-adrenergic receptor ligands. Proc. Natl. Acad. Sci. USA 2009, 106, 6843-6848.
67. Huang, D. Z.; Luthi, U.; Kolb, P.; Cecchini, M.; Barberis, A.; Caflisch, A. In silico discovery of β-secretase inhibitors. J. Am. Chem. Soc. 2006, 128, 5436-5443.
68. Huang, D. Z.; Luthi, U.; Kolb, P.; Edler, K.; Cecchini, M.; Audetat, S.; Barberis, A.; Caflisch, A. Discovery of cell-permeable nonpeptide inhibitors of β-secretase by high-throughput docking and continuum electrostatics calculations. J. Med. Chem. 2005, 48, 5108-5111.
69. Yu, W. M.; Guvench, O.; Mackerell, A. D., Jr.; Qu, C. K. Identification of Small Molecular Weight Inhibitors of Src Homology 2 Domain-Containing Tyrosine Phosphatase 2 (SHP-2) via in Silico Database Screening Combined with Experimental Assay. J. Med. Chem. 2008. 51(23), 7396-404.
70. Li, M.; Ni, N.; Chou, H. T.; Lu, C. D.; Tai, P. C.; Wang, B. Structure-based discovery and experimental verification of novel AI-2 quorum sensing inhibitors against Vibrio harveyi. ChemMedChem 2008, 3, 1242-9.
71. Chen, D.; Misra, M.; Sower, L.; Peterson, J. W.; Kellogg, G. E.; Schein, C. H. Novel inhibitors of anthrax edema factor. Bioorg. Med. Chem. 2008, 16, 7225-33.
72. Heinke, R.; Spannhoff, A.; Meier, R.; Trojer, P.; Bauer, I.; Jung, M.; Sippl, W. Virtual Screening and Biological Characterization of Novel Histone Arginine Methyltransferase PRMT1 Inhibitors. ChemMedChem 2008, 4, 69-77.
73. Honma, T.; Hayashi, K.; Aoyama, T.; Hashimoto, N.; Machida, T.; Fukasawa, K.; Iwama, T.; Ikeura, C.; Ikuta, M.; Suzuki-Takahashi, I.; Iwasawa, Y.; Hayama, T.; Nishimura, S.; Morishima, H. Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design. J. Med. Chem. 2001, 44, 4615-27.
74. Takano, Y.; Koizumi, M.; Takarada, R.; Kamimura, M. T.; Czerminski, R.; Koike, T. Computer-aided design of a factor Xa inhibitor by using MCSS functionality maps and a CAVEAT linker search. J. Mol. Graph. 2003, 22, 105-14.